Capricor Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Capricor Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Capricor Therapeutics Inc
Rating: 1.13233325
Author: Trendlyne DVM scores

about

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in mu...

19.48 0.36 (1.88%)

51.75% Fall from 52W High

158.6K

XNAS Volume

XNAS 17 Jul, 2026 10:13 AM (EDT)

Not Eligible

Expensive Valuation

6.8 / 100

Technically Neutral

38.5 / 100

1Yr Price target upside is 176%

10 analysts

Capricor Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Capricor Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in mu...

51.75% Fall from 52W High

SWOT Analysis

Capricor Therapeutics Inc Live Price Chart

Capricor Therapeutics Inc Live Price Chart